role advanced lipoprotein analysis practice pubmed ncbi abstract practitioners advanced lipoprotein analysis goal predicting risk individualizing lifestyle drug therapy cardiovascular prevention low-density lipoprotein ldl high-density lipoprotein hdl particle number size lipoprotein subfractionation apolipoproteins lipoprotein a met current standards biomarker evaluation remains determined tests incrementally add cardiovascular risk predicted traditional risk factors importantly determined treatment strategies guided targeting measures improve cardiovascular outcomes drug therapies alter advanced lipoprotein analysis parameters specifically niacin fenofibrate shown additionally reduce cardiovascular risk recent randomized trials high-risk patients treated statin therapy findings suggest advanced lipoprotein analysis-guided strategies reduce cardiovascular events lead increased adverse effects costs approach research establish role individualizing therapies cardiovascular prevention contrast large body evidence supports focusing ldl cholesterol reduction intensification statin therapy reduce cardiovascular risk copyright num american college cardiology foundation published elsevier rights reserved 
